MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.9600
+0.0600 (6.67%)
At close: Feb 27, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 4.6 million as of March 2, 2026. Its market cap has increased by 70.49% in one year.
Market Cap
4.60M
Enterprise Value
6.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.96
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 4.60M, a decrease of -94.23%. That is a compound annual growth rate of -63.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.60M | -23.16% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 7.26M |
| Cytophage Technologies | 7.11M |
| BioVaxys Technology | 6.83M |
| PharmaTher Holdings | 6.83M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.51M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |